Neurocrine Biosciences Shares Up 17.8% Since SmarTrend's Buy Recommendation (NBIX)
November 11, 2015 at 20:09 PM EST
SmarTrend identified an Uptrend for Neurocrine Biosciences (NASDAQ:NBIX) on October 5th, 2015 at $43.71. In approximately 1 month, Neurocrine Biosciences has returned 17.81% as of today's recent price of...